Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. WO2020223439 - AURONES ET MÉTHODES D'UTILISATION D'AURONES POUR TRAITER LA TUBERCULOSE

Numéro de publication WO/2020/223439
Date de publication 05.11.2020
N° de la demande internationale PCT/US2020/030623
Date du dépôt international 30.04.2020
CIB
A61K 31/00 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
31Préparations médicinales contenant des ingrédients actifs organiques 
CPC
A61K 31/343
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
34having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
343condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
A61K 31/404
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403condensed with carbocyclic rings, e.g. carbazole
404Indoles, e.g. pindolol
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
C07D 209/34
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
209Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
02condensed with one carbocyclic ring
04Indoles; Hydrogenated indoles
30with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
32Oxygen atoms
34in position 2
C07D 307/83
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
307Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
77ortho- or peri-condensed with carbocyclic rings or ring systems
78Benzo [b] furans; Hydrogenated benzo [b] furans
82with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
83Oxygen atoms
Déposants
  • MIDDLE TENNESSEE STATE UNIVERSITY [US]/[US]
  • UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION [US]/[US]
  • KONG, Ying [US]/[US]
  • YANG, Dong [US]/[US]
  • TAYLOR, Zachary E. [US]/[US]
  • HANDY, Scott [US]/[US]
  • ALTMAN, Elliot [US]/[US]
Inventeurs
  • KONG, Ying
  • YANG, Dong
  • TAYLOR, Zachary E.
  • HANDY, Scott
  • ALTMAN, Elliot
Mandataires
  • ARNESON, Laura
Données relatives à la priorité
62/840,78830.04.2019US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) AURONES AND METHODS OF USING AURONES TO TREAT TUBERCULOSIS
(FR) AURONES ET MÉTHODES D'UTILISATION D'AURONES POUR TRAITER LA TUBERCULOSE
Abrégé
(EN)
This disclosure describes compounds, compositions, and methods for treating or preventing infection or disease including, in some specific embodiments, treating or preventing tuberculosis and/or infection with Mycobacterium tuberculosis (Mtb). In one aspect, this disclosure describes aurones including, for example, aurone 9504, aurone 9505, aurone 9501, aurone 9510, aurone AA2A, and aurone AA8, compositions including aurones, and methods of using aurones for treating or preventing tuberculosis.
(FR)
La présente divulgation concerne des composés, des compositions et des méthodes de traitement ou de prévention d'une infection ou d'une maladie comprenant, dans certains modes de réalisation spécifiques, le traitement ou la prévention de la tuberculose et/ou d'une infection par Mycobacterium tuberculosis (Mtb). Dans un aspect, la présente divulgation concerne des aurones comprenant, par exemple, l'aurone 9504, l'aurone 9505, L'aurone 9501, l'aurone 9510, l'aurone AA2A, et l'aurone AA8, des compositions comprenant des aurones, et des méthodes d'utilisation d'aurones pour traiter ou prévenir la tuberculose.
Dernières données bibliographiques dont dispose le Bureau international